Sarepta Therapeutics Inc (NASDAQ:SRPT)

Delayed Data
As of Apr 20
 +0.30 / +2.27%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 19.50, with a high estimate of 45.00 and a low estimate of 14.00. The median estimate represents a +44.02% increase from the last price of 13.54.

Analyst Recommendations

The current consensus among 17 polled investment analysts is to Hold stock in Sarepta Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.06%
Growthannually -25.76%


Growthquarterly 2,503.41%
Growthannually -65.93%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account